Evidence map›Paper›PMID 34823911›Full record

ArticleVaccine2021

100 years of the Bacillus Calmette-Guérin vaccine.

Paulo J G Bettencourt, Simone A Joosten, Cecilia S Lindestam Arlehamn, Marcel A Behr, Camille Locht, Olivier Neyrolles

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paulo J G BettencourtCatholic University of Portugal, Lisbon, Portugal; Centre for Interdisciplinary Research in Health, Catholic University of Portugal, Lisbon, Portugal. Electronic address: pbettencourt@ucp.pt.
Simone A JoostenDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Cecilia S Lindestam ArlehamnCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
Marcel A BehrDepartment of Microbiology & Immunology, McGill University, Montréal, Canada; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, Canada; McGill International TB Centre, Montréal, Canada; Department of Medicine, McGill University Health Centre, Montréal, Canada.
Camille LochtUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, F-59000, France.
Olivier NeyrollesInstitut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adjuvants, ImmunologicBCG VaccineAdjuvants, ImmunologicBCG Vaccine

Identifiers

PMID34823911
PMCPMC8638750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.